Beclometasone dry-powder inhalation - Chiesi

Drug Profile

Beclometasone dry-powder inhalation - Chiesi

Alternative Names: Beclometasone DPI; Beclometasone Pulvinal - Chiesi; Beclomethasone dry-powder inhalation - Chiesi; Beclomethasone Pulvinal - Chiesi; ClenilPulvinal; Easivent BDP; Pulvinal Beclometasone

Latest Information Update: 18 Sep 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chiesi
  • Developer Chiesi; Trinity-Chiesi Pharmaceuticals
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 18 Sep 2001 Launched for Asthma in United Kingdom (Inhalation)
  • 09 Jul 2001 Launched for Asthma in Italy (Inhalation)
  • 07 Feb 2000 Registered for Asthma in Italy (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top